 CAMBRIDGE, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Oncorus, Inc. Nasdaq: ONCR, a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore Ted Ashburn, M.D., Ph.D., will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12, 2022 at 9:00 a.m. ET in New York, NY. 